--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About KPTI20260417P5
Biological Technology
Karyopharm Therapeutics Inc., was incorporated in Delaware on December 22, 2008. The company is a clinical-stage pharmaceutical company focused on the discovery and development of novel first-line drugs targeting nuclear transport targets for the treatment of cancer and critical diseases. The company's scientific expertise focuses on understanding the regulation of intracellular transport between the nucleus and cytoplasm.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
